A resolution expressing support for the designation of July 2026 as "National Sarcoma Awareness Month".

Whereas sarcoma is a rare cancer of the bones or connective tissues, such as nerves, muscles, joints, fat, and blood vessels, that can arise nearly anywhere in the body;
Whereas, in the United States—
about 18,000 individuals are diagnosed with sarcoma each year;
approximately 7,600 individuals die from sarcoma each year; and
over 236,000 individuals struggle with sarcoma at any given time;
Whereas, each year, about 1 percent of cancers diagnosed in adults and around 21 percent of cancers diagnosed in children are sarcoma;
Whereas more than 100 subtypes of sarcoma have been identified;
Whereas the potential causes of sarcoma are not well understood;
Whereas treatment for sarcoma can include surgery, radiation therapy, or chemotherapy;
Whereas sarcoma is often misdiagnosed and underreported; and
Whereas July 2026 would be an appropriate month to designate as National Sarcoma Awareness Month—
to raise awareness about sarcoma; and
to encourage more individuals in the United States to get properly diagnosed and treated: Now, therefore, be it
That the Senate supports the designation of July 2026 as National Sarcoma Awareness Month.